Summary of findings 6. Skills training versus standard care for both severe mental illness and substance misuse.
SKILLS TRAINING compared to STANDARD CARE for both severe mental illness and substance misuse | ||||||
Patient or population: people with both severe mental illness and substance misuse Settings: community and outpatient Intervention: SKILLS TRAINING Comparison: STANDARD CARE | ||||||
Outcomes | Illustrative comparative risks* (95% CI) | Relative effect (95% CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
Assumed risk | Corresponding risk | |||||
STANDARD CARE | SKILLS TRAINING | |||||
Leaving the study early: Lost to treatment Follow‐up: mean 12 months | 138 per 1000 | 196 per 1000 (28 to 1000) | RR 1.42 (0.20 to 10.1) | 122 (3 studies) | ⊕⊝⊝⊝ very low1,2 | |
Adverse event: Death | 79 per 1000 | 12 per 1000 (2 to 112) |
RR 0.15 (0.02 to 1.42 |
121 (1 study) |
⊕⊕⊝⊝ low3,4,5 | |
Substance use: Alcohol (C‐DIS‐R average score) Follow‐up: mean 12 months | See comment | See comment | Not estimable | See comment | See comment | Data were skewed and no estimate of effect was calculated between randomised arms. |
Substance use: Drug (non‐alcohol) (C‐DIS‐R average score) Follow‐up: mean 12 months | See comment | See comment | Not estimable | See comment | See comment | Data were skewed and no estimate of effect was calculated between randomised arms. |
Mental state | See comment | See comment | Not estimable | No data were available for analyses. | ||
Social functioning*: Role Functioning Scale: scale 1 to 7 Follow‐up: mean 12 months | The mean assessment of functioning in the intervention groups was 1.07 higher (1.15 lower to 3.29 higher) | 47 (1 study) | ⊕⊝⊝⊝ very low6,7 | * Global state data were not reported. NOTE: the scale is 1 to 7 and the difference observed is not of clinical importance and is not statistically significant. |
||
Quality of life/life satisfaction ‐ not measured | See comment | See comment | Not estimable | ‐ | See comment | Neither trial measured general life satisfaction. |
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio; | ||||||
GRADE Working Group grades of evidence High quality: further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: we are very uncertain about the estimate. |
1 Risk of Bias: Rated as VERY SERIOUS: Blinding was not possible and performance bias may be present. It was unclear whether assessors were blinded and detection bias may be present. Attrition bias was a high risk in Hellerstein 1995 with 47% loss to follow‐up at 4 months and 64% at 8 months with no reasons for drop‐outs provided and not addressed in analysis. 2 Imprecision: Rated as SERIOUS: The event rate was low (zero events in one trial) with a wide confidence interval. 3 Risk of Bias: Rated as SERIOUS: The trial outcomes were self‐reported abstinence and there is no report of whether raters were blind to treatment allocation when assessing the participant's self‐report.
4 Inconsistency: this is not possible to evaluate as there is only a single study.
5 Imprecision: The single trial has a small sample size of 121 with very low event rates. The confidence interval crosses the line of no effect and appreciable harm. 6 Risk of Bias: Rated as SERIOUS: Blinding was not possible and performance bias may be present. It was unclear whether 7 Imprecision: Rated as VERY SERIOUS: The single trial has a very small sample size (N =47) and the confidence interval is wide.